TAK-960

DB33612InvestigationalSmall molecule

TAK-960: Overview.

Mechanism: Pharmacologically active on Serine/threonine-protein kinase PLK1
Curator reviewed
Formula / weight: C₂₇H₃₄F₃N₇O₃ · 561.61 g/mol (avg)
Code names: TAK-960

Resolves to

Compound

Structure

InChIKeyGWRSATNRNFYMDI-UHFFFAOYSA-NSMILESCOC1=CC(C(=O)NC2CCN(C)CC2)=C(F)C=C1NC1=NC2=C(C=N1)N(C)C(=O)C(F)(F)CN2C1CCCC1

Targets

What you can answer from here — as of September 16, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with TAK-960, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.